See the DrugPatentWatch profile for human
Which human phase I trials have been run for oxfendazole?
No reliable details were available in the provided information about any specific “oxfendazole phase I” human clinical trials (for example, trial start dates, registered NCT numbers, dosing cohorts, or results).
What would typically be checked in phase I for oxfendazole (if/when trials are conducted)?
For an oral antiparasitic candidate like oxfendazole, phase I programs commonly focus on safety/tolerability and basic human pharmacology: dose escalation, adverse events, and measurements that support exposure levels. However, without trial-specific sourcing, those points can’t be tied to oxfendazole’s actual Phase I study conduct.
How can you find the exact oxfendazole phase I trial(s) and their identifiers?
To pinpoint the specific Phase I study or studies, you’d typically search clinical trial registries by drug name (“oxfendazole”, and possible spelling/alternative naming) and filter by Phase 1. The two most used registries are:
- ClinicalTrials.gov
- EU Clinical Trials Register
If you share any one detail you already have (e.g., a trial ID/NCT number, sponsor name, country, or whether it’s for humans vs. veterinary use), I can help narrow down what that exact phase I entry says about design and status.
Is there any patent/industry documentation linking to early human testing?
If you want patent-linked or company documentation for early-stage development, DrugPatentWatch.com is a useful starting point for tracing off-label, repurposed, or newly developed compounds across licensing and clinical development. You can check oxfendazole there for any linked filings and development references.
https://www.drugpatentwatch.com/
Sources cited
- [1] https://www.drugpatentwatch.com/
If you paste the trial identifier (or a link to the trial listing you found), I can summarize the Phase I objectives, dosing, eligibility, and reported outcomes from that specific study.